Decentralized Real-world evidence RWE data

Decentralized Clinical Trials Capabilities and Solutions

Our DCT ecosystem optimizes decentralized clinical trials

The goal of the PPD™ clinical research business of Thermo Fisher Scientific has always been to optimize the patient and site’s experience within a decentralized setting. We leverage years of industry-leading experience along with new capabilities to build a comprehensive collective of solutions for decentralized clinical trials. Tim Rich, Vice President of Digital and Decentralized solutions discusses how our DCT ecosystem enables consultants to precisely apply the right strategies at the right times, benefiting trials, sites, and patients.


Telemedicine enables patients to stay connected to their clinicians, utilizing convenient digital tools that don’t require frequent site visits. Sites can continue their standard of care, reduce protocol deviations, and collect quality data – all with limited interruption.